SHRM.CN - Champignon Brands Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.4150
+0.0500 (+13.70%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.3650
Open0.3600
Bid0.3900 x N/A
Ask0.4200 x N/A
Day's Range0.3450 - 0.4200
52 Week Range0.3450 - 0.4200
Volume2,569,689
Avg. VolumeN/A
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CHAMPIGNON EXPANDS PRECLINICAL PIPELINE WITH MEASURED PSILOCYBIN DOSAGES STUDIES AT UNIVERSITY OF MIAMI
    GlobeNewswire

    CHAMPIGNON EXPANDS PRECLINICAL PIPELINE WITH MEASURED PSILOCYBIN DOSAGES STUDIES AT UNIVERSITY OF MIAMI

    Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a health and wellness company specializing in the formulation of medicinal mushrooms health products and novel delivery platforms for the pharmaceutical and nutraceutical industries, has entered into a definitive agreement to acquire Tassili Life Sciences Corp. (“Tassili”), expanding the Company’s preclinical trial pipeline, as well as its aggregation of broad intellectual property (IP) related to the development of novel psychedelics therapeutics and their delivery systems, targeting multiple pathological psychological diseases. Tassili, in partnership with a multidisciplinary team of scientists and physicians at the University of Miami are working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries (mTBI) and/or post-traumatic stress disorder (PTSD).

  • REPEAT - CHAMPIGNON BRANDS APPOINTS DR. JOSEPH GABRIELE, ERNST & YOUNG 2018 HEALTH CARE ENTREPRENEUR OF THE YEAR AND DELIVRA™ INVENTOR TO SPECIAL ADVISORY COMMITTEE
    GlobeNewswire

    REPEAT - CHAMPIGNON BRANDS APPOINTS DR. JOSEPH GABRIELE, ERNST & YOUNG 2018 HEALTH CARE ENTREPRENEUR OF THE YEAR AND DELIVRA™ INVENTOR TO SPECIAL ADVISORY COMMITTEE

    Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a health and wellness company specializing in the formulation of a suite of medicinal mushroom health products, as well as novel delivery platforms for the pharmaceutical and nutraceutical industries, continues to bolster its Special Advisory Committee via the appointment of qualified experts in the areas of formulation chemistry, transdermal delivery systems, psychotherapeutics, mycology and molecular pharmacology. Champignon is pleased to announce the appointment of Dr. Joseph Gabriele, a molecular pharmacologist specializing in signal transduction within the central nervous system, to its Special Advisory Committee.

  • CHAMPIGNON BRANDS APPOINTS DR. JOSEPH GABRIELE, ERNST & YOUNG 2018 HEALTH CARE ENTREPRENEUR OF THE YEAR AND DELIVRA™ INVENTOR TO SPECIAL ADVISORY COMMITTEE
    GlobeNewswire

    CHAMPIGNON BRANDS APPOINTS DR. JOSEPH GABRIELE, ERNST & YOUNG 2018 HEALTH CARE ENTREPRENEUR OF THE YEAR AND DELIVRA™ INVENTOR TO SPECIAL ADVISORY COMMITTEE

    Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a health and wellness company specializing in the formulation of a suite of medicinal mushroom health products, as well as novel delivery platforms for the pharmaceutical and nutraceutical industries, continues to bolster its Special Advisory Committee via the appointment of qualified experts in the areas of formulation chemistry, transdermal delivery systems, psychotherapeutics, mycology and molecular pharmacology. Champignon is pleased to announce the appointment of Dr. Joseph Gabriele, a molecular pharmacologist specializing in signal transduction within the central nervous system, to its Special Advisory Committee.

  • CEO of Champignon Brands Shares Strategic Goals in Exclusive NetworkNewsWire Broadcast
    GlobeNewswire

    CEO of Champignon Brands Shares Strategic Goals in Exclusive NetworkNewsWire Broadcast

    NEW YORK, March 23, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Champignon Brands Inc. (SHRM.CN) today announces the broadcast of its audio interview with NetworkNewsAudio (“NNA”), one of 40+ brands in the InvestorBrandNetwork (“IBN”). Champignon Brands CEO Gareth Birdsall joins NNW’s Stuart Smith in an interview that delves into the company’s strategic plan to expand its portfolio and become a preeminent player in the emerging psychedelic medicine arena. Headquartered in Vancouver, Champignon aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

  • CHAMPIGNON BRANDS ANNOUNCES NORMAL COURSE ISSUER BID FOR COMMON SHARES OF THE CORPORATION
    GlobeNewswire

    CHAMPIGNON BRANDS ANNOUNCES NORMAL COURSE ISSUER BID FOR COMMON SHARES OF THE CORPORATION

    VANCOUVER, British Columbia, March 20, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTC: SHRMF), a health and wellness company.

  • IIROC Trade Resumption - SHRM
    CNW Group

    IIROC Trade Resumption - SHRM

    IIROC Trade Resumption - SHRM

  • CHAMPIGNON BRANDS EXPANDS ALTERNATIVE MEDICINE IP PORTFOLIO WITH KETAMINE, ADAPTOGENIC DELIVERY SYSTEMS/FORMULATIONS
    GlobeNewswire

    CHAMPIGNON BRANDS EXPANDS ALTERNATIVE MEDICINE IP PORTFOLIO WITH KETAMINE, ADAPTOGENIC DELIVERY SYSTEMS/FORMULATIONS

    Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a health and wellness company specializing in the formulation of a suite of medicinal mushrooms and mushroom-infused products, today introduces new proprietary intellectual property (“IP”) into its vertically integrated alternative medicine product range. The Company is pleased to announce its entry into a definitive agreement, signed March 18, 2020, to acquire Novo Formulations Ltd. (“Novoformulations”).

  • IIROC Trading Halt - SHRM
    CNW Group

    IIROC Trading Halt - SHRM

    IIROC Trading Halt - SHRM

  • REPEAT: Champignon Brands to Acquire Craft Mushroom Cultivator
    GlobeNewswire

    REPEAT: Champignon Brands to Acquire Craft Mushroom Cultivator

    Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (496.F), a wellness company specializing in medicinal mushroom and mushroom-infused products, continues to accelerate its vertical integration through the addition of craft mushroom production, manufacturing and research capabilities. The Company is pleased to announce it has entered into a definitive agreement (the “Agreement”) to acquire Artisan Growers Ltd. (“Artisan Growers”), a British Columbia based craft mushroom cultivator and supplier. Artisan Growers operates a craft mushroom cultivation facility capable of producing an assortment of organic craft mushroom varietals including Lion’s Mane, Chaga, Reishi and Agaricus Blazei.

  • Champignon Brands to Acquire Craft Mushroom Cultivator
    GlobeNewswire

    Champignon Brands to Acquire Craft Mushroom Cultivator

    Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (496.F), a wellness company specializing in medicinal mushroom and mushroom-infused products, continues to accelerate its vertical integration through the addition of craft mushroom production, manufacturing and research capabilities. The Company is pleased to announce it has entered into a definitive agreement (the “Agreement”) to acquire Artisan Growers Ltd. (“Artisan Growers”), a British Columbia based craft mushroom cultivator and supplier. Artisan Growers operates a craft mushroom cultivation facility capable of producing an assortment of organic craft mushroom varietals including Lion’s Mane, Chaga, Reishi and Agaricus Blazei.

  • Champignon Brands Spotlighted in Publication Discussing Mushrooms in Medicine
    GlobeNewswire

    Champignon Brands Spotlighted in Publication Discussing Mushrooms in Medicine

    NEW YORK, March 05, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Champignon Brands Inc. (SHRM.CN) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 40+ brands in the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. With the legalization of medical cannabis in many jurisdictions, regulators and businesses are re-examining which natural drugs are legally available for consumers. Mushrooms, with their powerful ability to affect brain chemistry, look set to become the next major legalization drive in America.

  • Champignon Brands Completes Listing; to Form Special Advisory Committee
    GlobeNewswire

    Champignon Brands Completes Listing; to Form Special Advisory Committee

    Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM), a wellness company specializing in the formulation and distribution of a suite of medicinal mushroom-infused products, began trading on the Canadian Securities Exchange (the “CSE”) on March 2, 2020, quoted under the ticker symbol “SHRM”. In February 2020, the Company successfully completed an Initial Public Offering (the “IPO”) via lead agent PI Financial Corp. Champignon will also look to secure a listing on the Frankfurt Stock Exchange and quotation on the OTC Marketplace in the US as soon as practicable. Champignon’s anticipated tri-listing will afford its current shareholders pre-eminent liquidity, all while contributing to a genuine global presence through improved accessibility for international capital flows.

  • Champignon Brands Grants Stock Options
    GlobeNewswire

    Champignon Brands Grants Stock Options

    Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) announces that it has granted a total of 3,900,000 stock options to its directors, officers, consultants and advisors. Champignon Brands Inc. is a Canadian based company dedicated to the distribution of artisanal medicinal mushroom-infused products. Champignon continues to be inspired by sustainability, as all of its eligible SKUs are organic, non-GMO and vegan certified.

  • EuroLife to Feature Champignon Vitality Teas in Spielhaus Boardgame Cafe
    Newsfile

    EuroLife to Feature Champignon Vitality Teas in Spielhaus Boardgame Cafe

    Product Launch in Toronto, Ontario to Precede Launch Across Germany, Switzerland and the United Kingdom Toronto, Ontario--(Newsfile Corp. - March 2, 2020) - EuroLife Brands (CSE: EURO) (FSE: 3CMA) (OTC Pink: EURPF) ("EuroLife" or the "Company"), a vertically integrated enterprise focused on the pan-European hemp, cannabinoid, and health and wellness sector, is pleased to announce the introduction of Vitality Superteas from Champignon Brands Inc., (CSE: SHRM) at the Spielhaus Boardgame Cafe (Spielhaus) in Toronto, Ontario. ...

  • Champignon Brands Inc. Completes Initial Public Offering
    GlobeNewswire

    Champignon Brands Inc. Completes Initial Public Offering

    Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) is pleased to announce that it successfully completed its initial public offering (the “IPO”) of 18,916,667 common shares (the “Shares”) of Champignon at a price of $0.15 per Share for total gross proceeds of $2,837,500.05 (the “Proceeds”). Champignon paid to the Agent a cash commission equal to 8% of the Proceeds and granted the Agent and its sub agents non-transferable warrants entitling the Agent and its sub agents to purchase a total of 1,513,333 Common Shares at a price of $0.30 per Common Share until February 28, 2022. Champignon’s common shares were listed on the Canadian Securities Exchange (“CSE”) effective February 27, 2020 and halted pending completion of the IPO.